Serum anticholinergic activity and motor performance in elderly persons.

BACKGROUND Medications prescribed to elderly persons often have an anticholinergic effect, as do many commonly used over-the-counter drugs. Anticholinergic medications are known to produce psychomotor slowing, especially in older persons. METHODS The present study examined whether the cumulative anticholinergic load present in the serum of community volunteers was associated with decrements on tests of psychomotor performance (gait speed and simple manual response time) known to predict falls in elderly persons. RESULTS Serum anticholinergic activity (SAA) was relatively low in this group; however, an elevated SAA was associated with a significant slowing in both gait speed and simple response time. CONCLUSION Cumulative anticholinergic burden may be one of the factors contributing to an increased risk of falls in the older population.

[1]  M. Cesari,et al.  Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  J. Flacker,et al.  Endogenous anticholinergic substances may exist during acute illness in elderly medical patients. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  K. Rasmussen,et al.  Olanzapine, a novel atypical antipsychotic, reversesd-amphetamine-induced inhibition of midbrain dopamine cells , 1996, Psychopharmacology.

[4]  S R Lord,et al.  Simple physiological and clinical tests for the accurate prediction of falling in older people. , 1996, Gerontology.

[5]  H. Dodge,et al.  Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[6]  T. Oberg,et al.  Basic gait parameters: reference data for normal subjects, 10-79 years of age. , 1993, Journal of rehabilitation research and development.

[7]  M. Feinberg.  The Problems of Anticholinergic Adverse Effects in Older Patients , 1993, Drugs & aging.

[8]  P. Tariot,et al.  Age-related decline in central cholinergic function demonstrated with scopolamine , 1996, Psychopharmacology.

[9]  L. Tune,et al.  Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. , 1992, The American journal of psychiatry.

[10]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[11]  B. Pollock,et al.  Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. , 2003, Archives of general psychiatry.

[12]  Abraham Weizman,et al.  Anticholinergic Burden and the Risk of Falls Among Elderly Psychiatric Inpatients: A 4-Year Case-Control Study , 2002, International Psychogeriatrics.

[13]  M. Bayes,et al.  The Probability of , 2001 .

[14]  J. VanSwearingen,et al.  Assessing recurrent fall risk of community-dwelling, frail older veterans using specific tests of mobility and the physical performance test of function. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  M. Hiscock,et al.  Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients. , 1988, The American journal of psychiatry.